Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
9,750.62
9,152.57
7,905.21
7,840.80
5,545.52
5,975.78
5,806.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,750.62
9,152.57
7,905.21
7,840.80
5,545.52
5,975.78
5,806.35
Raw Material Cost
3,928.27
4,013.93
3,094.52
2,880.15
2,051.80
2,124.06
2,181.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1,619.62
1,485.54
1,504.67
147.03
162.69
1,413.37
1,316.33
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
250.80
144.67
87.90
80.57
96.68
140.73
135.81
Selling and Distribution Expenses
3,674.47
3,301.86
2,877.83
2,853.96
2,337.36
2,676.95
2,514.00
Other Expenses
-187.04
-163.02
-159.26
-22.76
-25.94
-155.41
-145.21
Total Expenditure (Excl Depreciation)
7,602.75
7,315.79
5,972.35
5,734.11
4,389.16
4,801.00
4,695.04
Operating Profit (PBDIT) excl Other Income
2147.9
1836.8000000000002
1932.8999999999999
2106.7
1156.4
1174.8
1111.3
Other Income
-1,141.77
-1,135.34
-837.25
-616.02
-471.63
-459.39
-426.94
Operating Profit (PBDIT)
1,620.68
1,268.59
1,625.94
1,938.55
1,141.37
1,229.33
1,109.66
Interest
250.80
144.67
87.90
80.57
96.68
140.73
135.81
Exceptional Items
202.61
102.12
27.80
-32.92
5.41
0.00
0.00
Gross Profit (PBDT)
5,822.35
5,138.64
4,810.69
4,960.65
3,493.72
3,851.73
3,625.31
Depreciation
614.58
567.15
505.51
447.88
456.63
513.94
425.28
Profit Before Tax
957.92
658.89
1,060.32
1,377.19
593.47
574.66
548.56
Tax
231.91
205.07
408.65
279.38
96.08
108.57
172.94
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
652.60
417.19
571.83
982.32
560.35
403.27
321.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
652.60
417.19
571.83
982.32
560.35
403.27
321.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
73.41
36.62
79.84
127.20
39.91
63.82
54.55
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
726.01
453.81
651.67
1,109.53
600.26
467.09
376.32
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,110.21
8,103.12
7,771.85
7,547.85
6,627.90
5,905.83
5,143.06
Earnings per share (EPS)
16.38
11.49
16.73
28.41
16.21
11.66
9.31
Diluted Earnings per share
16.38
11.49
16.73
28.41
16.21
11.66
9.31
Operating Profit Margin (Excl OI)
22.03%
20.07%
24.76%
26.87%
20.85%
19.66%
19.14%
Gross Profit Margin
16.13%
13.4%
19.81%
23.28%
18.94%
18.22%
16.77%
PAT Margin
6.69%
4.56%
7.23%
12.53%
10.1%
6.75%
5.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 6.53% vs 15.78% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 59.98% vs -30.37% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 14.91% vs -2.41% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 73.32% vs 64.62% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Ceylon Hospitals Plc With
Figures in Million
Consolidate Annual Results
Change(LKR)
Change(%)
Net Sales
9,750.62
11,012.69
-1,262.07
-11.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,750.62
11,012.69
-1,262.07
-11.46%
Raw Material Cost
3,928.27
7,105.43
-3,177.16
-44.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,619.62
1,971.24
-351.62
-17.84%
Power Cost
0
0
0.00
Manufacturing Expenses
250.80
927.89
-677.09
-72.97%
Selling and Distribution Expenses
3,674.47
3,039.85
634.62
20.88%
Other Expenses
-187.04
-289.91
102.87
35.48%
Total Expenditure (Excl Depreciation)
7,602.75
10,145.28
-2,542.53
-25.06%
Operating Profit (PBDIT) excl Other Income
2,147.87
867.41
1,280.46
147.62%
Other Income
-1,141.77
173.68
-1,315.45
-757.40%
Operating Profit (PBDIT)
1,620.68
1,867.09
-246.41
-13.20%
Interest
250.80
927.89
-677.09
-72.97%
Exceptional Items
202.61
0.41
202.20
49,317.07%
Gross Profit (PBDT)
5,822.35
3,907.26
1,915.09
49.01%
Depreciation
614.58
826.01
-211.43
-25.60%
Profit Before Tax
957.92
113.61
844.31
743.17%
Tax
231.91
280.26
-48.35
-17.25%
Provisions and contingencies
0
0
0.00
Profit After Tax
652.60
56.38
596.22
1,057.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
652.60
56.38
596.22
1,057.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
73.41
0.00
73.41
Other related items
0.00
0.00
0.00
Consolidated Net Profit
726.01
56.38
669.63
1,187.71%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
11,110.21
4,912.86
6,197.35
126.15%
Earnings per share (EPS)
16.38
0.04
16.34
40,850.00%
Diluted Earnings per share
16.38
0.04
16.34
40,850.00%
Operating Profit Margin (Excl OI)
22.03%
7.88%
0.00
14.15%
Gross Profit Margin
16.13%
8.53%
0.00
7.60%
PAT Margin
6.69%
0.51%
0.00
6.18%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 975.06 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 6.53% vs 15.78% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 72.60 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 59.98% vs -30.37% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 276.24 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 14.91% vs -2.41% in Mar 2024
Annual - Interest
Interest 25.08 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 73.32% vs 64.62% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.03%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
